Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

Conditions:   Cognitively Normal Older Adults;   Hypertension;   Subjective Cognitive Decline;   Family History of Dementia Intervention:   Drug: Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine) Sponsors:   Rong Zhang;   National Institute on Aging (NIA);   Texas Health Resources;   Michigan State University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials